Table 2.
Compounds | Molecular Formula | Molecular Weight | HBA | HBD | TPSA | Log P−0.7–5 | Log S 0–6 | GI Absorption | BBB Permeant | CYPP1A2 Inhibitor | CYP2D6 Inhibitor | Log Kp (Skin Permeation), cm/s | Lipinski Violations | Ghose Violations | Veber Violations | Bioavailability Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glycyrrhizin | C42H62O16 | 822.93 | 16 | 8 | 267.04 | 1.49 | −6.24 | Low | No | No | No | −9.33 | 3 MW > 500, NorO > 10, NHorOH > 5 | 3 MW > 480, MR > 130, atoms > 70 | 1 TPSA > 140 | 0.11 |
18,β Glycyrrhetinic acid | C30H46O5 | 470.68 | 4 | 2 | 74.6 | 5.13 | −6.15 | High | No | No | No | −4.27 | 1 MLOGP.4.16 | 3 WLOGP > 5.6, MR > 130. | Yes | 1.56 |
Rhodiolin | C25H20O10 | 480.42 | 10 | 5 | 159.05 | 2.3 | −4.99 | Low | No | No | No | −7.02 | 0 | 1 MW > 480 | 1 TPSA > 140 | 0.55 |
Baicalin | C21H18O11 | 446.36 | 11 | 6 | 187.12 | 0.25 | −3.41 | Low | No | No | No | −8.23 | 3 NorO.10, NHorOH > 5 | Yes | 1 TPSA > 140 | 0.11 |
Hesperidin | C28H34O15 | 610.56 | 15 | 8 | 234.29 | −1.06 | −3.28 | Low | No | No | No | −10.12 | 3 MW > 500, NorO > 10, NHorOH > 5 | 4 MW > 480, WLOGP < 0.4, MR > 130, #atoms > 70 | 1 TPSA > 140 | 0.17 |
Solophenol A | C30H36O6 | 492.6 | 6 | 4 | 107.22 | 5.69 | −7.5 | Low | No | No | No | −3.8 | 0 | 4 MW > 480, WLOGP < 0.4, MR > 130, #atoms > 71 | 1 TPSA > 140 | 0.55 |
Naringin | C26H30O14 | 566.51 | 14 | 8 | 225.06 | −0.99 | −2.68 | Low | No | No | No | −10.39 | 3 MW > 500, NorO > 10, NHorOH > 5 | 3MW > 480, WLOGP < 0.4 MR > 130, | 1 TPSA > 140 | 0.17 |
Lopinavir | C37H48N4O5 | 628.8 | 5 | 4 | 120 | 4.37 | −6.64 | High | No | No | No | −5.93 | 1 MW > 500 | 3 MW > 480, MR > 130, #atoms > 70 | 1 Rotors > 10 | 0.55 |
HBA: Number of Hydrogen bond acceptors HBD: Number of hydrogen bond donor, TPSA: Tropological polar surface area.